PERSPECTA

News from every angle

Back to headlines

Merck reportedly ready to the splits as Keytruda patent cliff looms. Market shrugs

23 Feb, 13:23 — 23 Feb, 13:23
PostShare

Sources

Showing 1 of 1 sources